Baker Bros. Advisors »

Insmed Inc convertible security shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Insmed Inc convertible security shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Insmed Inc convertible security

Tip: Access up to 7 years of quarterly data

All positions including Insmed Inc convertible security held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed Inc convertible security by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $56M 33M 1.71

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Summit Therapeutics (SMMT)
Kymera Therapeutics (KYMR)
Edgewise Therapeutics (EWTX)
Alkermes SHS (ALKS)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)
Replimune Group (REPL)
Denali Therapeutics (DNLI)

View all positions for Baker Bros. Advisors

Top funds holding Insmed Inc convertible security

Deerfield Management Company
Baker Bros. Advisors
Skaana Management
DeepCurrents Investment Group
Jpmorgan Chase & Co
Bnp Paribas Investment Partners
Warberg Asset Management
Elequin Capital
Kohlberg Kravis Roberts & Co
Verition Fund Management
Bnp Paribas Arbitrage, Snc
Bank of America Corporation
Patron Partners Advisors
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Insmed Inc convertible security